Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
971.00    -14.00 (-1.42%)
Bid:
980.20
Ask:
980.60
Spread: 0.40 (0.041%)
Market Cap: £4.75b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Transaction in Own Shares

10 Dec 2025 07:00

RNS Number : 9020K
Babcock International Group PLC
10 December 2025
ย 

Babcock International Group PLC - Transaction in Own Shares

ย 

10 December 2025

ย 

Transaction in Own Shares

ย 

Babcock International Group PLC (the Company) announces today it has purchased the following number of its ordinary shares of 60 pence each through Jefferies International Limited.

Date of purchase:

09 December 2025

Aggregate number of ordinary shares purchased:

15

Highest price paid per share (ยฃ per share):

11.9600

Lowest price paid per share (ยฃ per share):

11.9300

Volume weighted average price paid per shareย (ยฃ):

11.9533

The Company intends to hold the purchased shares in treasury.

Since 24 July 2025, the Company has purchased 7,560,806 shares at a cost of ยฃ83,755,739.55.

Following the above transaction, the Company holds 5,757,846 of its ordinary shares in treasury and has 499,838,751 ordinary shares in issue (excluding treasury shares).

The table below contains detailed information about the purchases referred to above.

Schedule of purchases

ย 

Shares purchased:

Babcock International Group PLC (ISIN: GB0009697037)

Date of purchases:

09 December 2025

Investment firm:

Jefferies International Limited

Aggregate information

ย 

Venue

Aggregated number of ordinary shares purchased

Volume-weighted average price per share (ยฃ)

Lowest price per share (ยฃ)

Highest priceper share (ยฃ)

London Stock Exchange

15

11.9533

11.9300

11.9600

CBOE CXE

0

0.0000

0.0000

0.0000

CBOE BXE

0

0.0000

0.0000

0.0000

Turquoise

0

0.0000

0.0000

0.0000

Aquis

0

0.0000

0.0000

0.0000

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Jefferies International Limited on behalf of the Company is set out below.

Transaction Time

Time Zone

Volume

Price

Currency

Platform Code

Transaction reference number

ย 

15:43:10

GMT

10

11.960

GBP

XLON

00503658682TRLO1.1.1

15:43:10

GMT

1

11.960

GBP

XLON

00503658683TRLO1.1.1

15:51:40

GMT

1

11.950

GBP

XLON

00503663283TRLO1.1.1

15:54:31

GMT

1

11.930

GBP

XLON

00503664741TRLO1.1.1

15:54:31

GMT

2

11.930

GBP

XLON

00503664740TRLO1.1.1

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
POSFLFFDFSLAIIE
Date   Source Headline
21st Nov 201611:13 amRNSContract Award
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.